Sleep Quality Evolution: Dreem Under CPAP
Key facts
- Who runs it
- University Hospital, Grenoble
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 70 people enrolled
- Started
- 3 Oct 2022
- Ended
- 13 Apr 2026
- Type of study
- Interventional
- Treatments tested
- Deem 3 Headband
- Record updated
- 17 June 2026
Who can take part
- Age
- 30 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Patients newly diagnosed with OSA requiring CPAP treatment
- Patients able to use a mobile application on a smartphone or tablet
- Patients with access to a wi-fi internet connection at home
- Patients agreeing to remote monitoring of CPAP compliance data by the home care provider
- Patients who have signed consent to participate in the study
- Subjects affiliated to a social security
Who cannot take part
- Patients treated with a sleep aid (sleeping medications)
- Persons in a period of exclusion from another study or ongoing participation in a drug study
- Patients with severe chronic obstructive or restrictive lung disease with or without oxygen
- Patients with unstable cardiovascular disease or severe heart failure requiring hospitalization within the last three months or meeting New York Heart Association criteria, Class III or IV disease
- Patients already treated for OSA
- Subjects listed in articles L1121-5 to L1121-8: pregnant women, feeding and parturients, subjects deprived of liberty by judicial or administrative decision, persons under legal protection
- Subjects likely, at the investigator's discretion, to be uncooperative or noncompliant with the obligations inherent to participation in the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Continuous positive airway pressure (CPAP) has a caricatural effect in reducing nocturnal respiratory abnormalities and improving the micro-and macrostructure of sleep. Studies characterizing the improvement of acute sleep parameters after the initiation of CPAP are limited to one or two nights of polysomnographic recording. This is related to the cost of performing these studies with repeated recordings in the laboratory and to the acceptability by patients to perform multiple nights of recordings.
Read full original descriptionShow less
Investigators currently have powerful and reliable methods allowing us to carry out nights at home in the patient's ecosystem, in real-life conditions. The characterization of sleep parameters by these methods is equivalent to a polysomnographic recording.
These technological innovations will allow us to characterize sleep before the initiation of CPAP treatment during several nights performed at home. Investigators will then be able to characterize the kinetics and stability of the improvement of sleep parameters in patients with obstructive sleep apnea syndrome in whom continuous positive airway pressure is initiated.
These data will be original and will serve as exploratory data to judge whether the objective improvement of sleep parameters in the first weeks of treatment is associated with improvement in sleepiness, quality of life, and compliance with treatment.
The group in the trial
- Technological innovations and CPAPTreatment being tested
Patients will be equipped with 4 devices: a Dreem 3 Headband, a pulse oximeter, a continuous glucose sensor, and a pedometer. In parallel they will be equipped by the CPAP at home by Icadom.
Treatment: Deem 3 Headband
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evolution of Sleep Quality During the Initiation of Continuous Positive Airway Pressure Treatment in Obstructive Sleep Apnea Syndrome: An Exploratory Study
- Record updated
- 17 June 2026